Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.

Rationale for combination therapy with galantamine and memantine in Alzheimer's disease. J Clin Pharmacol. 2006 Jul; 46(7 Suppl 1):17S-26S.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.